Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

about

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

Item

http://www.wikidata.org/entity/Q39158809

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@en

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@nl

type

Item

label

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@en

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@nl

prefLabel

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@en

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@nl

P1476

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

@en

P2093

Alexandra L Ghaben

http://www.w3.org/2001/XMLSchema#string

Philipp E Scherer

http://www.w3.org/2001/XMLSchema#string

P2860

Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges

Clinical efficacy and safety of statins in managing cardiovascular risk.

The role of thyroid hormone and brown adipose tissue in energy homoeostasis

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity.

Thyroid hormones and cardiovascular disease.

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

P304

762-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.117.310452

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28254797

http://www.w3.org/2001/XMLSchema#string

P932

5338644

http://www.w3.org/2001/XMLSchema#string